by Rhoda Wilson, Expose News:

For the second time in two years, WHO has declared mpox, formerly known as monkeypox, a public health emergency of international concern.  Below we look at whether WHO’s grounds for declaring an emergency are valid and what they will do next.

Our advice is do not comply and do not take the vaccine.

TRUTH LIVES on at https://sgtreport.tv/

The World Health Organisation (“WHO”) first declared mpox a public health emergency of international concern (“PHEIC”) in July 2022.

On Wednesday, WHO Director-General Dr. Tedros Adhanom Ghebreyesus announced that the upsurge of mpox in the Democratic Republic of the Congo (“DRC”) and a growing number of countries in Africa constitutes a PHEIC under the International Health Regulations (2005).

Two vaccines already in use for mpox are recommended by WHO’s Strategic Advisory Group of Experts on Immunisation, and approved by authorities in Nigeria and the DRC.

Last week, the Director-General triggered the process for Emergency Use Listing for mpox vaccines, which will accelerate vaccine access for lower-income countries which have not yet issued their own national regulatory approval. Emergency Use Listing also enables partners including GAVI and UNICEF to procure vaccines for distribution.

Read more: WHO declares mpox a public health emergency again, Western Standard, 14 August 2024

World Health Organization (WHO) declares #mpox outbreak a Public Health Emergency of International Concern (PHEIC). pic.twitter.com/pAlOx9Bq13

— WHO Ghana (@WHOGhana) August 14, 2024

As The Conversation noted:

The spread of mpox through certain African countries led the Africa Centres for Disease Control and Prevention to declare earlier this week mpox a public health emergency of continental security. This is the first time the organisation has issued such an alert since it was established in 2017.

In 2022, an epidemic of mpox swept through non-endemic countries, including beyond Africa. This was a variant of clade II originating from Nigeria, called clade IIb. This was sexually transmitted, predominantly affecting men who have sex with men, and had a low fatality rate.

That epidemic peaked in 2022, with vaccines made available to people at risk in high-income countries, but there has been an uptick in 2024.

At the same time, large clade I epidemics were occurring in the Democratic Republic of the Congo, but with far less attention … most cases and deaths in the Democratic Republic of the Congo have been children. This means most transmission there is non-sexual and is likely to have occurred through close contact or respiratory aerosols.

WHO has declared mpox a global health emergency. What happens next? The Conversation, 15 August 2024

Unsafe Vaccines

The Conversation goes on to state the claims that the mpox variant in DRC is different from the rest of Africa where “vaccines were not available … even in 2023.”  DRC has clade I while other countries had clade IIb, for which vaccines were distributed.

The vaccines distributed are called Jynneos in some countries and Imvamune or Imvanex in others.  Jynneos is a smallpox vaccine which is claimed to be effective against mpox.  However, the smallpox vaccine is neither safe nor effective.

“Smallpox vaccine, when used routinely in babies, was considered the most dangerous vaccine available. It led to the deaths of several people per million administrations,” Dr. Meryl Nass warned when WHO declared mpox a PHEIC the first time.  In 2021, “the CDC perhaps inadvertently admitted it had no reliable evidence for either safety or efficacy [for the Jynneos vaccine],” she said.

A few months later Dr. Geert Vanden Bossche warned that young children should not be vaccinated with any type of smallpox vaccine. “The current monkeypox pandemic is to be considered an indirect consequence of the unfortunate covid mass vaccination programme … The monkeypox vaccination campaigns that are currently kicked off are not only likely to have a detrimental impact on individual health (particularly in covid unvaccinated children and vulnerable people) but should also be considered at risk of provoking a true public health emergency of international concern,” he said.

Related: The mantra “safe and effective” began with smallpox vaccines; were they “safe and effective”?

Jynneos is a live, attenuated vaccinia virus; Modified Vaccinia Ankara (“MVA”) virus which is an attenuated strain of the poxvirus Chorioallantois Vaccinia virus strain Ankara (“CVA”). CVA is not a naturally occurring virus, it was derived through serial passage in chicken embryo fibroblasts (“CEF”). The serial passages in CEF resulted in significant genetic changes to the original vaccinia virus strain Ankara.

The Ankara strain originated in Turkey.  In 1953, the vaccinia virus strain Ankara was brought from Turkey – where it had been propagated on the skin of calves and donkeys at the Turkish vaccine institute in Ankara for smallpox vaccine production – to the Institute for Infectious Diseases and Tropical Medicine at the University of Munich.  Herrlich and Mayr cultivated the virus on the chorioallantois membranes (“CAM”) of embryonated chicken eggs and therefore named it as Chorioallantois Vaccinia virus Ankara (“CVA”).  At the Bavarian State Institute for Vaccines, CVA was grown on the skin of calves to manufacture smallpox vaccine for the vaccination campaigns in Munich in 1954/1955.

Read More @ Expose-News.com